Gemcitabine (Gemzar)

gemcitabine · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

46 regulatory and trial events tracked for Gemcitabine (Gemzar), covering 2007-07-25 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma [Phase 2]